Some studies suggest that, in addition to α-synuclein, further protein deposits in the striatum, in particular Aβ and less tau, may be a morphologic substrate for the distinction between DLB and PD with dementia [124,125]; these are currently mostly distinguished upon clinical criteria. This evidence concerns the gene MAPT and Parkinson disease.